Original Research
Published on 06 Nov 2023
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1222435
- 4,542 views
- 8 citations



